Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia

Pediatric Blood and Cancer

Volumn 59, Issue 1, 2012, Pages 170-172

  Miller, Scott T ^a   Rey, Kathy ^a   He, Jin ^b   Flanagan, Jonathan ^b   Fish, Billie J ^c   Rogers, Zora R ^d   Wang, Winfred C ^b   Ware, Russell E ^e  

^a KINGS COUNTY HOSPITAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Clinical Trials & Surveys Corp   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BABY HUG; Drug toxicity; Hydroxycarbamide; Infant; Poisoning

Indexed keywords

ACTIVATED CARBON; HYDROXYUREA; PLACEBO;

ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BONE MARROW SUPPRESSION; CASE REPORT; CHILD; CONSERVATIVE TREATMENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG INTOXICATION; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFANT; INGESTION; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT DURATION; TREATMENT OUTCOME;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROXYUREA; INFANT; OVERDOSE;

EID: 84861217720     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23244     Document Type: Article

References (20)

1. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995; 332: 1317-1322.
2. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001; 97: 3628-3632.
3. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999; 94: 1550-1554.
4. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001; 139: 790-796.
5. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. JAMA 2003; 289: 1645-1651.
6. Steinberg MH, McCarthy WF, Castro O, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol 2010; 85: 403-408.
7. Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design. Pediatr Blood Cancer 2010; 54: 250-255.
8. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle cell anaemia: A multicentre randomised controlled trial (BABY HUG). Lancet 2011; 377: 1663-1672.
9. Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 2010; 115: 5300-5311.
10. Heeney MM, Whorton MR, Howard TA, et al. Chemical and functional analysis of hydroxyurea oral solutions. J Pediatr Hematol Oncol 2004; 26: 179-184.
11. Harrod VL, Howard T, Abboud MR, et al. Chemical and functional analysis of generic hydroxyurea formulations. Pediatr Hematol Oncol 2008; 25: 423-429.
12. Belt RJ, Haas CD, Kennedy J, et al. Studies of hydroxyurea administered by continuous infusion: Toxicity, pharmacokinetics, and cell synchronization. Cancer 1980; 46: 455-462.
13. Wray JD. Methaemoglobinaemia caused by hydroxycarbamide (hydroxyurea) ingestion in a dog. J Small Anim Pract 2008; 49: 211-215.
14. Gwilt PR, Tracewell WG. Pharmacokinetics and pharmacodynamics of hydroxyurea. Clin Pharmacokinet 1998; 34: 347-358.
15. Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992; 79: 2555-2565.
16. Rodriguez GI, Kuhn JG, Weiss GR, et al. A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. Blood 1998; 91: 1533-1541.
17. Yan JH, Ataga K, Kaul S, et al. The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease. J Clin Pharmacol 2005; 45: 434-445.
18. Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: Baseline data from the BABY HUG trial. J Pediatr 2010; 156: 66-70, e61.
19. Manoguerra AS, Cobaugh DJ. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons. Clin Toxicol (Phila) 2005; 43: 1-10.
20. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention. Poison treatment in the home. Pediatrics 2003; 112: 1182-1185.